License Agreement in Regard to a Patented Invention by the Technion-Israel Institute of Technology, exclusively held by Accellta Ltd., Has Been Entered with iPS PORTAL

We executed a non-exclusive license agreement with iPS PORTAL, Inc. on a patented invention by the Technion-Israel Institute of Technology entitled “Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same” (Our Ref. No. AJ089 / Patent No. JP4613069), which has been exclusively held by Accellta Ltd., and of which we have been granted a non-exclusive license with sublicense right in Japan.

We are sure that the patent will contribute to many company’s business since the patent is highly important for using iPS cells under xeno-free and feeder cells-free conditions. Please feel free to contact us if you are interested in the patent for your iPS cell business in Japan.